- Home
- SUPN vs TUYA Comparison
SUPN vs TUYA Comparison
Compare SUPN & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- TUYA
- Stock Information
- Founded
- SUPN 2005
- TUYA 2014
- Country
- SUPN United States
- TUYA China
- Employees
- SUPN N/A
- TUYA N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- TUYA Computer Software: Prepackaged Software
- Sector
- SUPN Health Care
- TUYA Technology
- Exchange
- SUPN Nasdaq
- TUYA Nasdaq
- Market Cap
- SUPN 1.8B
- TUYA 1.6B
- IPO Year
- SUPN 2012
- TUYA 2021
- Fundamental
- Price
- SUPN $31.91
- TUYA $2.42
- Analyst Decision
- SUPN Hold
- TUYA
- Analyst Count
- SUPN 2
- TUYA 0
- Target Price
- SUPN $36.00
- TUYA N/A
- AVG Volume (30 Days)
- SUPN 460.6K
- TUYA 2.4M
- Earning Date
- SUPN 05-06-2025
- TUYA 05-20-2025
- Dividend Yield
- SUPN N/A
- TUYA 4.48%
- EPS Growth
- SUPN N/A
- TUYA N/A
- EPS
- SUPN 1.11
- TUYA 0.03
- Revenue
- SUPN $667,997,000.00
- TUYA $311,642,000.00
- Revenue This Year
- SUPN N/A
- TUYA $20.05
- Revenue Next Year
- SUPN $8.74
- TUYA $17.58
- P/E Ratio
- SUPN $28.64
- TUYA $72.46
- Revenue Growth
- SUPN 11.82
- TUYA 27.64
- 52 Week Low
- SUPN $25.53
- TUYA $1.28
- 52 Week High
- SUPN $40.28
- TUYA $4.63
- Technical
- Relative Strength Index (RSI)
- SUPN 47.71
- TUYA 46.26
- Support Level
- SUPN $31.56
- TUYA $2.35
- Resistance Level
- SUPN $32.85
- TUYA $2.66
- Average True Range (ATR)
- SUPN 0.78
- TUYA 0.15
- MACD
- SUPN -0.08
- TUYA -0.01
- Stochastic Oscillator
- SUPN 24.38
- TUYA 12.50
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, it has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.